Navigation Links
Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
Date:11/19/2012

trategic Alliance Focused Primarily on Metabolic Diseases.  In August 2012, Regulus entered into a strategic alliance with AstraZeneca AB ("AZ") to discover, develop, and commercialize microRNA therapeutics for three exclusive targets focused on cardiovascular and metabolic diseases and oncology.  AZ made an upfront payment of $3.0 million and purchased $25.0 million of Regulus' common stock in a private placement that closed concurrently with the IPO. In addition, Regulus is eligible to receive preclinical, clinical and commercialization milestone payments of up to $509.0 million, as well as royalties. 
  • Established Research Collaboration to Explore microRNA Biomarkers for Multiple Sclerosis.  In August 2012, Regulus formed a collaboration with Biogen Idec Inc. ("Biogen Idec") to explore microRNA biomarkers for multiple sclerosis.  Regulus received an upfront payment of $750,000 and is eligible to receive milestone payments of up to $1.3 million.  Regulus also received $5.0 million from the sale of a convertible note to Biogen Idec which converted into shares of Regulus' common stock at the closing of the IPO. 
  • Re-Aligned Board of Directors.  In November 2012, Douglas E. Williams, Ph.D., Executive Vice President of Research and Development at Biogen Idec, joined Regulus' Board of Directors.  Concurrently, Stanley T. Crooke, M.D., Ph.D., Chairman of the Board and CEO of Isis Pharmaceuticals, Inc., and Barry E. Greene, President and Chief Operating Officer of Alnylam Pharmaceuticals, Inc., stepped down from the Board and their respective Board committees. 
  • Third Quarter 2012 Financial Results & HighlightsAs of September 30, 2012, Regulus had cash, cash equivalents and short-term investments of $30.9 million compared to $38.1 million at December 31, 2011.  The decrease in cash, cash equivalents and short-term investments was the result of approximately $17.7 m
    '/>"/>

    SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
    2. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
    3. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
    4. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
    5. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
    6. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
    7. Grupo Casa Saba Reports - Grupo Casa Saba Announces its Intention to Delist From the New York Stock Exchange
    8. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
    9. ULURU Inc. Reports Third Quarter 2012 Financial Results
    10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
    11. China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... MYL ) shareholder vote regarding its planned unsolicited ... Mylan,s offer to Perrigo shareholders have always been, and ... reflection of the value available to Perrigo shareholders, and ... has allowed its shareholders to consider," said Joseph ...
    (Date:8/28/2015)... , Joint research by Prof. Kim ... , Published in ,Stem Cells Translational Medicine, (IF ... multiple IV administration of Adipose-derived MSC , Increase ... , Commercialization within 5 years expected ... adult mesenchymal stem cells (MSCs) may extend healthy life ...
    (Date:8/28/2015)... , August 28, 2015 The ... reach USD 49.12 billion by 2020, growing at a ... a new report by Grand View Research, Inc. Monitoring ... of 49.7% from 2014 to 2020.      ... population along with rising incidences of chronic diseases such ...
    Breaking Medicine Technology:Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
    ... , SANTA ROSA, Calif. , Feb. 16 ... Osseoplasty™ procedures in Europe . The procedures were performed in ... Incorporado, SL, the largest independent medical device distributor in Europe ... weeks in the United Kingdom , Germany and ...
    ... , , CRANBURY, N.J. , ... today announced financial results for the fourth quarter and full year ... product pipeline related to its key strategic priorities for 2010.  Additionally, ... achieve its key milestone of completing enrollment for its Phase 3 ...
    Cached Medicine Technology:Osseon Launches in Europe 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 3Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 4Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 5Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 6Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 7Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 8Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 9Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 10Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 11
    (Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... / Device Model, Cisco Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s ... to Work in Healthcare by Modern Healthcare and will be honored at an ... its eighth year, the Best Places to Work in Healthcare program recognizes outstanding employers ...
    (Date:8/28/2015)... ... August 28, 2015 , ... CARF International announced that West ... day treatment and intensive family based services. , By pursuing and achieving accreditation, ... pursuit of excellence. As a nonprofit charity for more than 50 years, West ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... loyalty at a low cost. Personalized with practice contact information and logos, Calendars ... Dental offices can also incorporate Calendars into seasonal mailings, thank you and welcome ...
    (Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Northridge ... on Zoom teeth whitening. For just $199, patients can currently receive a one hour ... in-office teeth whitening procedures, but it includes a number of unique features that can ...
    Breaking Medicine News(10 mins):Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
    ... Boston, MA -- Eating disorders among adolescent girls and ... and lead to dangerous weight-control behaviors, such as self-induced ... weight. The middle school age is a high risk ... dangerous weight-control behaviors that affect millions of Americans. Researchers ...
    ... 8.7 percent of U.S. children age 8 to ... fewer than half receive treatment, according to a ... Pediatrics & Adolescent Medicine, one of the JAMA/Archives ... of attention-deficit/hyperactivity disorder (ADHD) is on the rise, ...
    ... age 12 to 19 years who received family-based treatment ... than those who received supportive psychotherapy, which explores the ... in the September issue of Archives of General Psychiatry, ... is a disabling eating disorder with a prevalence of ...
    ... need, researchers say , , MONDAY, Sept. 3 (HealthDay News) ... disorder (ADHD), but only 32 percent of them are ... conclusion of a landmark new study, the first of ... standard" of diagnostic criteria -- the Diagnostic and Statistical ...
    ... SDAX as Per September 6, 2007 ... Outside the Normal Schedule, Decision on Possible ... Germany, September 3 Gerresheimer AG has,been listed in the Prime Standard ... largest IPOs of the year, with a total,issue volume of more than ...
    ... Belgium, September 3 KFH has announced that ... ISO 13485 and ISO,9001:2000 quality management systems with ... Dr Sally Sennitt, MD, says: "We are delighted,to ... systems,through working with BSI. It is a major ...
    Cached Medicine News:Health News:School-based overweight prevention program may cut risk of eating disorders among girls 2Health News:Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD 2Health News:Family-based treatment more effective than supportive psychotherapy in treating bulimia 2Health News:9% of U.S. Kids Have ADHD 2Health News:9% of U.S. Kids Have ADHD 3
    ...
    ...
    Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium....
    Solid 13.5 mm wide by 5 mm deep blades. Edge of blades serrated. Dull finish....
    Medicine Products: